We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020.
Last week, Mylan and Pfizer’s Upjohn unit unveiled proposed branding for their new joint venture, Viatris, meaning “three paths” in Latin. In the press release, Mylan noted that the three colors – blue, yellow, and purple – were chosen to signify the company’s three commitments – access, leadership, and partnership.
The post Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation appeared first on Big Molecule Watch.